Navigation Links
Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass
Date:2/3/2009

'Plumbing the Depths' White Paper Reports More Than 75% of Biotech Firms Expect to Establish or Enhance a Corporate Partnership in Next Three Years

NEW YORK, Feb. 3 /PRNewswire/ -- More biotechnology companies will be compelled to explore business partnerships and strategic alliances in a more restrictive lending environment, according to "Plumbing the Depths," a new white paper report published today by CPA firm Rothstein Kass (www.rkco.com). Results were based on the findings of two successive research studies designed to shed light on the difficulties and opportunities facing small and mid-sized biotechnology firms. Survey results from November 2008 were contrasted with data compiled in early September 2008 to reveal how attitudes and perceptions have been altered by continuing market volatility. In November, nearly 77 percent survey respondents suggested that they plan to establish or enhance a corporate partnership in the next three years, up from just below 68 percent in September.

"'Plumbing the Depths' combines extensive empirical data with the insight and experience of our Commercial Services Group principals to deliver unbiased analysis of the issues impacting biotechnology industry capitalization," said Steven Kass, co-managing principal at Rothstein Kass. "As trusted audit and tax principals to a growing range of vertical industry segments, we recognize short-term challenges businesses are facing and are committed to helping these organizations refine their operations in volatile market conditions."

"In part because of their lengthy product development cycles, biotech firms are largely dependent on ready access to affordable capital. During periods of economic growth, industry innovation has been fueled by a wide range of investors willing to make speculative allocations to the sector in pursuit of outsized returns," said Tom Angell, principal-in-ch
'/>"/>

SOURCE Rothstein Kass
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights
2. Credit-card-sized platform for volatile compound analysis CAREER project goal
3. Global Confidence in Innovation Holds Despite Economy
4. Automation Alley Releases Report on State of Southeast Michigans Technology Economy
5. Creators of Britains Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008
6. Clostridium difficile Infection: Current Challenges and Controversies
7. White Paper Addresses FDA Approval Challenges Facing Combination Product Manufacturers
8. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
9. Can Algae Biofuels Satisfy the World's Growing Biofuel Needs? Upcoming Webinar Shares the Latest Commercialization Strategies and Challenges
10. The Plasmodium vivax genome provides new routes and challenges in the global fight against malaria
11. Isilon CTO Addresses Life Science Data Storage Challenges at Harvard Medical Schools BioMedical HPC Leadership Summit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...n German . , Whether it,s CD packaging, con...Frequency Identification) are increasingly finding...le to label objects or goods and identify them aut...nner can read and process the data contained in th...r production conditions of up to 100 degrees Celsi...
(Date:11/24/2009)...ssador to also Visit Detroit , ... Appia, French Ambassador for International Invest... Agency, , , , ,What: Ambassador Appia is availab...ss initiatives adopted by France to further develo... innovation and development., , ,When: Available f...
(Date:11/24/2009)...lif., Nov. 24 Two more prestigious...ation,s leading online job board and careers site ... and Columbia University are now members of the jo...ing Institutions. ,, The job board, www.biocar...life sciences. While there are hundreds of life sc...
(Date:11/24/2009)...EYKJAVIK, Iceland, November 24 /PRNewswire-FirstCa... announced that it has received notice from,the Na...mmon stock will be,suspended as of November 30, 20...ties and Exchange Commission, which will remove de... the company files an appeal to the Nasdaq,Listing...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...icals, Boosts Oncology Pipeline With Up to Three P... Phase III in 2009, INDIANAPOLIS and NEW YO...d ImClone Systems Inc. (Nasdaq: IMCL ) today,anno...es have approved a,definitive merger agreement und... cash tender offer of $70.00 per share, or approxi...
...a Bethlehem, PA based pharmaceutical software and ...ew out-of-the-box labeling solution based on Docum...ation. SPL for DCM provides a complete labeling c...elease 4 submission standard mandated by the FDA, ...mily of pharmaceutical labeling solutions. , ...
...sciences, Inc. (Nasdaq: MGRM ) today announced th...Nasdaq Stock Market dated October 1, 2008,indicati...days, the bid,price of Monogram,s common stock has...ent for continued listing under Nasdaq rules., Th...will be provided,with 180 calendar days, or until ...
Other Biology Technology:Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 2Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 3Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 4Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 5Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 6Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 7Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 8Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 9Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 10Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 11Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 12Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 13Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 14Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 15Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 16Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements 2Monogram Receives NASDAQ Notification 2Monogram Receives NASDAQ Notification 3Monogram Receives NASDAQ Notification 4
(Date:11/25/2009)...er 11, firefighters, police officers and ambulance...orld Trade Center complex. They battled to save pe... survivors, tackled fires and evacuated as many pe...stimated 17,000 people. And making their jobs even...ightened workers and their relatives jammed mobile...
(Date:11/25/2009)...I, NOVEMBER 25, 2009 Soil is the linchpin of the ...osphere meet. Despite that, many students see soil...ng more. Soil science educators are challenged wit...gnize the critical importance of soil in the envir...ce and earth science teachers at University of Neb...
(Date:11/25/2009)...tate University assistant professors recently rece...(NSF) to continue research beneficial to understan...000. , Christopher Blackwood, assistant professo...arded grants to support two separate research proj...tter Decomposer Communities and Functions from the...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Sinovac Obtains Production License for H1N1 Vaccine 13826 1Sinovac Obtains Production License for H1N1 Vaccine 13826 2Sinovac Obtains Production License for H1N1 Vaccine 13826 3Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 1Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 2Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 3Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 4Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 5
...ew technique for printing extraordinarily thin lin...ess expensive and more versatile electronic displa...technologies. , Solving a fundamental and long-st...eveloped a method for shooting stable jets of elec...echnique, which produced lines just 100 nanometers...
...llions of nearly invisible wires may hold the answ...of alternative energy. , The Department of Engine...nergy and the Ontario Centres of Excellence (OCE) ...ization of nanowire technology in the production o...technology developed at McMaster is able to trap m...
...logists from the University of Leicester propose t... brought about an end to one epoch of Earths histo...asiewicz and Mark Williams at the University of Le...ommission of the Geological ,Society of London hav...y. , In it, they suggest humans have so changed t...
Other Biology News:Fine print: New technique allows fast printing of microscopic electronics 2Fine print: New technique allows fast printing of microscopic electronics 3Nanowires hold promise for more affordable solar cells 2Man-made changes bring about new epoch in Earth's history 2
Mouse Anti-Bcr-abl Monoclonal Antibody, Unconjugated, Clone 7C6 from Abcam
Rabbit Anti-Bcl-G, C-Terminus Polyclonal Antibody, Unconjugated from AnaSpec
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, FITC Conjugated, Clone LO-MM-9 from Cell Sciences
Anti-TIMP-4 (Tissue Inhibitor of Metalloproteinases-4), Loop #3 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: